BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

668 related articles for article (PubMed ID: 28263886)

  • 1. Gene editing in mouse zygotes using the CRISPR/Cas9 system.
    Wefers B; Bashir S; Rossius J; Wurst W; Kühn R
    Methods; 2017 May; 121-122():55-67. PubMed ID: 28263886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysing the outcome of CRISPR-aided genome editing in embryos: Screening, genotyping and quality control.
    Mianné J; Codner GF; Caulder A; Fell R; Hutchison M; King R; Stewart ME; Wells S; Teboul L
    Methods; 2017 May; 121-122():68-76. PubMed ID: 28363792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simplified CRISPR tools for efficient genome editing and streamlined protocols for their delivery into mammalian cells and mouse zygotes.
    Jacobi AM; Rettig GR; Turk R; Collingwood MA; Zeiner SA; Quadros RM; Harms DW; Bonthuis PJ; Gregg C; Ohtsuka M; Gurumurthy CB; Behlke MA
    Methods; 2017 May; 121-122():16-28. PubMed ID: 28351759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome editing using CRISPR/Cas9-based knock-in approaches in zebrafish.
    Albadri S; Del Bene F; Revenu C
    Methods; 2017 May; 121-122():77-85. PubMed ID: 28300641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precision genome editing using CRISPR-Cas9 and linear repair templates in C. elegans.
    Paix A; Folkmann A; Seydoux G
    Methods; 2017 May; 121-122():86-93. PubMed ID: 28392263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards mastering CRISPR-induced gene knock-in in plants: Survey of key features and focus on the model Physcomitrella patens.
    Collonnier C; Guyon-Debast A; Maclot F; Mara K; Charlot F; Nogué F
    Methods; 2017 May; 121-122():103-117. PubMed ID: 28478103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Versatile and precise gene-targeting strategies for functional studies in mammalian cell lines.
    Wassef M; Luscan A; Battistella A; Le Corre S; Li H; Wallace MR; Vidaud M; Margueron R
    Methods; 2017 May; 121-122():45-54. PubMed ID: 28499832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR/Cas9-mediated genome editing in plants.
    Liu X; Xie C; Si H; Yang J
    Methods; 2017 May; 121-122():94-102. PubMed ID: 28315486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct Generation of Conditional Alleles Using CRISPR/Cas9 in Mouse Zygotes.
    Pritchard CEJ; Kroese LJ; Huijbers IJ
    Methods Mol Biol; 2017; 1642():21-35. PubMed ID: 28815491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of the production of knock-in alleles by CRISPR/Cas9 microinjection into the mouse zygote.
    Raveux A; Vandormael-Pournin S; Cohen-Tannoudji M
    Sci Rep; 2017 Feb; 7():42661. PubMed ID: 28209967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CRISPR/CAS9, the King of Genome Editing Tools].
    Bannikov AV; Lavrov AV
    Mol Biol (Mosk); 2017; 51(4):582-594. PubMed ID: 28900076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An optimized electroporation approach for efficient CRISPR/Cas9 genome editing in murine zygotes.
    Tröder SE; Ebert LK; Butt L; Assenmacher S; Schermer B; Zevnik B
    PLoS One; 2018; 13(5):e0196891. PubMed ID: 29723268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of genome editing through CRISPR-Cas9 engineering.
    Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
    Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precision genome editing in the CRISPR era.
    Salsman J; Dellaire G
    Biochem Cell Biol; 2017 Apr; 95(2):187-201. PubMed ID: 28177771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene editing and clonal isolation of human induced pluripotent stem cells using CRISPR/Cas9.
    Yumlu S; Stumm J; Bashir S; Dreyer AK; Lisowski P; Danner E; Kühn R
    Methods; 2017 May; 121-122():29-44. PubMed ID: 28522326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Easi-CRISPR: a robust method for one-step generation of mice carrying conditional and insertion alleles using long ssDNA donors and CRISPR ribonucleoproteins.
    Quadros RM; Miura H; Harms DW; Akatsuka H; Sato T; Aida T; Redder R; Richardson GP; Inagaki Y; Sakai D; Buckley SM; Seshacharyulu P; Batra SK; Behlke MA; Zeiner SA; Jacobi AM; Izu Y; Thoreson WB; Urness LD; Mansour SL; Ohtsuka M; Gurumurthy CB
    Genome Biol; 2017 May; 18(1):92. PubMed ID: 28511701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electroporation of AsCpf1/RNP at the Zygote Stage is an Efficient Genome Editing Method to Generate Knock-Out Mice Deficient in Leukemia Inhibitory Factor.
    Kim YS; Kim GR; Park M; Yang SC; Park SH; Won JE; Lee JH; Shin HE; Song H; Kim HR
    Tissue Eng Regen Med; 2020 Feb; 17(1):45-53. PubMed ID: 32002841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Editing in Mouse Zygotes Using the CRISPR/Cas9 System.
    Wefers B; Wurst W; Kühn R
    Methods Mol Biol; 2023; 2631():207-230. PubMed ID: 36995669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas9-Mediated Insertion of loxP Sites in the Mouse Dock7 Gene Provides an Effective Alternative to Use of Targeted Embryonic Stem Cells.
    Bishop KA; Harrington A; Kouranova E; Weinstein EJ; Rosen CJ; Cui X; Liaw L
    G3 (Bethesda); 2016 Jul; 6(7):2051-61. PubMed ID: 27175020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering the Delivery System for CRISPR-Based Genome Editing.
    Glass Z; Lee M; Li Y; Xu Q
    Trends Biotechnol; 2018 Feb; 36(2):173-185. PubMed ID: 29305085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.